International Normalized Ratio (INR)

The single fact that resolves most confusion: there is no one "good" INR. A 1.0 is reassuring in someone untreated and would alarm a cardiologist watching a patient on warfarin, because it means the protection has worn off. A 2.5 is the success story in that same patient and would be investigated in someone taking nothing. The result only means something once you know which group the person is in. The PT versus INR comparison walks through how the raw seconds become the standardized ratio.

Left to itself, prothrombin time is a local measurement. The chemical that triggers clotting in the tube, called thromboplastin, varies between manufacturers, and a more sensitive batch produces a longer time for the same blood. Before standardization, a warfarin patient who moved or switched labs could get a different verdict on identical blood.

The fix is arithmetic the lab does for you. Each reagent carries a published sensitivity figure, the international sensitivity index, and the lab raises the patient-to-normal time ratio to that power. The result is the INR, a single scale every accredited lab reports the same way. It is why your clinic can adjust a dose from a number drawn down the street or in another country and trust it the way it trusts its own machine. For the anatomy of what the underlying stopwatch test is actually timing, the prothrombin time page covers the clotting pathway and the liver's role in making the factors involved.

On warfarin, the target is a moving thing because the drug works by blunting vitamin K, and vitamin K comes and goes with daily life. Because warfarin works by blocking vitamin K recycling, a sudden change in leafy-green intake can shift the INR even when the dose hasn't changed. The number drifts when the balance between drug and vitamin K shifts, which it does for ordinary reasons.

Pulling in the other direction, eating noticeably more vitamin K than usual, such as a sudden run of large salads or kale, tends to lower INR and can leave a warfarin patient under-protected. The guidance from drug-safety sources is not to avoid these foods but to keep intake steady, so the dose the clinic set stays matched to the diet it was set against. Big swings, up or down, are what move the number.

INR is built specifically for warfarin and for spotting a clotting problem in someone untreated, such as advanced liver disease, where the organ that makes clotting factors can no longer keep up. It is not a general "how thick is my blood" gauge, and it says little about the other half of the clotting system.

It also does not monitor the newer blood thinners. The direct oral anticoagulants, apixaban and its relatives, hit a single clotting factor at a fixed dose in a predictable way, so they are taken without the regular INR draws warfarin demands, and INR doesn't reliably reflect their effect anyway. That freedom from monitoring is part of why they are chosen so often now, though warfarin is still the right drug for some conditions, including mechanical heart valves. INR also has nothing to say about heparin, the hospital blood thinner tracked by a separate clock, the activated partial thromboplastin time.

Prothrombin time and its INR are one line of the coagulation panel, the set of tests that map clot timing from different angles. Alongside it sit the activated partial thromboplastin time and fibrinogen, the raw rope the body weaves into a clot, with D-dimer marking clot that has already been broken down. The coagulation panel guide shows how those lines read as one picture rather than four separate alarms.

For anyone on warfarin, the single value matters far less than the run of values. A 2.6 means one thing as a steady reading and quite another if last month was 1.7 and the month before 3.4: the same number, but a dose that has not yet settled. Watching the trend over time is how a clinic tells a stable patient from one still being dialed in, which is most of what the test is really for.